MedPath

BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program

Not Applicable
Completed
Conditions
Neonatal Death
Maternal Morbidity
Stillbirth
Maternal Death
Interventions
Behavioral: WHO Safe Childbirth Checklist Program
Registration Number
NCT02148952
Lead Sponsor
Harvard School of Public Health (HSPH)
Brief Summary

The purpose of this study is to measure the impact of a checklist-based childbirth safety program (the WHO Safe Childbirth Checklist Program) on reduction of severe maternal, fetal, and newborn harm in institutional deliveries in north India.

Detailed Description

The WHO Safe Childbirth Checklist Program is a quality improvement program designed to support health workers to deliver evidence-based practices to women and newborns around the time of institutional childbirths. At the program's core is the Safe Childbirth Checklist, a 31-item list of essential practices that target the major causes of maternal and newborn mortality in low-resource settings globally. The program was developed over 3 years by a partnership of WHO and HSPH, working with a large international network of experts and stakeholders in maternal, fetal, and newborn health. Pilot testing of the program at a public-sector birth center in south India demonstrated dramatic improvements in health worker adherence to essential childbirth-related clinical care standards. The current study is a matched-pair, cluster randomized trial to measure the efficacy of the program in reducing severe maternal and newborn harm. This trial will be conducted at approximately 120 health facilities in Uttar Pradesh, India.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
157689
Inclusion Criteria
  • For measuring outcomes, inclusion criteria are all mothers admitted to a study site for childbirth and newborn babies who are to be followed-up. In case a mother or baby from an enrolled site is referred out to another facility (before or after delivery) the mother-baby dyad will be included in the study and the outcome will be allocated to the referring facility
  • For a smaller subset of birth events (approximately 4,650 deliveries total), health worker practices will be observed to measure the impact of the SCC program on delivery of essential practices, as a secondary outcome. A convenience sample of women who agree to observation and their babies cared for by the health workers around the time of childbirth at the facility during data collectors' duty hours will be included in this component of the study.
Exclusion Criteria
  • Mothers who have been referred into the facility by an inter-facility transfer.
  • Mothers being managed for abortion.
  • Mothers who refuse consent for follow-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention Health FacilityWHO Safe Childbirth Checklist ProgramWHO Safe Childbirth Checklist Program
Primary Outcome Measures
NameTimeMethod
Percentage of Participants With Composite Measure of Perinatal Death, Maternal Death, or Maternal Severe Complications Within 7 Days0-7 days after delivery

The primary outcome was a composite outcome of events occurring within the first 7 days after delivery, incorporating stillbirth; early neonatal death; maternal death; or self-reported maternal severe complications, including seizures, loss of consciousness for more than 1 hour, fever with foul-smelling vaginal discharge, hemorrhage, or stroke.

Secondary Outcome Measures
NameTimeMethod
Count of Participants With Perinatal Death Within 7 Days0-7 days

Count of participants with perinatal death within 7 days (combined stillbirth or neonatal death)

Count of Participants With Stillbirth0-7 days after delivery

Newborn outcome; rate of stillbirth

Count of Participants With Newborn Referral0-7 days after delivery

Newborn outcome; Newborn referral

Count of Participants With Hysterectomy Within 7 Days0-7 days after delivery

Rate of hysterectomy within 7 days

Count of Mothers Returning to Facility for a Health Problem Within 7 Days0-7 days after delivery

Maternal Outcome; Rate of need for follow-up care for Mother

Percentage of Participants With Perinatal Death or Maternal Death Within 7 Days0-7 days after delivery

Percentage of participants with composite rate of perinatal death and maternal death within 7 days

Count of Participants With Maternal Referral, Before or After Delivery0-7 days after delivery

Maternal outcome; Rate of maternal inter-facility transfer

Count of Participants With Early Neonatal Death0-7 days after delivery

Newborn outcome; rate of early neonatal death

Count of Participants With Maternal Death0-7 days after delivery

Maternal outcome; rate of maternal death

Count of Participants With Cesarean SectionAround the time of delivery during facility stay, an expected average of 2 days (although individual patients may vary)

Rate of cesarean section

Count of Newborns Returning to Facility for a Health Problem Within 7 Days0-7 days after delivery

Newborn outcome; Rate of need for follow-up care for newborn (or at least one newborn in case of twins)

Count of Participants With Severe Maternal Complications0-7 days after delivery

Maternal outcome; any severe maternal complication within 7 days

Count of Participants With Blood Transfusion Within 7 Days0-7 days after delivery

Rate of blood transfusion within 7 days

Trial Locations

Locations (1)

PSI

🇮🇳

Lucknow, Uttar Pradesh, India

© Copyright 2025. All Rights Reserved by MedPath